Dietary standing and survival of 8247 most cancers sufferers with or with out diabetes mellitus-results from a potential cohort examine
Background: The variety of most cancers sufferers with diabetes mellitus (DM) is steadily rising. Little is thought in regards to the dietary standing of this inhabitants. This examine characterised the dietary standing and survival of most cancers sufferers with diabetes in contrast with these with out diabetes.
Strategies: A complete of 8247 most cancers sufferers had been prospectively enrolled from 72 hospitals in China and adopted till August 2019. A worldwide estimation of the dietary standing was carried out for every participant utilizing standardized instruments. The outcomes had been cancer-specific survival (CSS) and general survival (OS).
Outcomes: The incidence of diabetes was 7.6% in the entire inhabitants. Compared with the non-DM group, the DM group had larger physique weight, however the same fat-free mass, a decrease handgrip energy and a decreased Karnofsky efficiency rating. A better proportion of sufferers with diabetes had been chubby/overweight as indicated by BMI. The proportion of sufferers who had been prone to malnutrition (evaluated by PG-SGA) was larger within the DM group (rating ≥ 4, 56.7% vs 52.9%). Sufferers with DM confirmed a worse CSS (4-year CSS, 62% vs 73%) and OS (4-year OS 39% vs 52%). Diabetes was related to an elevated threat of each cancer-specific (hazard ratio (HR) = 1.282, 95% confidence interval (CI) 1.070-1.536) and general (HR = 1.206, 95% CI 1.040-1.399) mortality.
Conclusions: Most cancers sufferers with diabetes had a bigger physique mass however decrease muscle energy, poorer efficiency standing and better incidence of malnourishment. Diabetes was related to compromised survival. Tailor-made dietary intervention is important for this subpopulation of sufferers.
.

anti- VEGF antibody |
|||
FNab09391 | FN Test | 100µg | EUR 658.5 |
Description: Antibody raised against VEGF |
Anti- VEGF antibody |
|||
FNab09933 | FN Test | 100µg | EUR 658.5 |
Description: Antibody raised against VEGF |
Anti-VEGF antibody |
|||
PAab09391 | Lifescience Market | 100 ug | EUR 463.2 |
Anti-VEGF antibody |
|||
STJ119887 | St John's Laboratory | 100 µl | EUR 471.6 |
Description: This gene is a member of the PDGF/VEGF growth factor family. It encodes a heparin-binding protein, which exists as a disulfide-linked homodimer. This growth factor induces proliferation and migration of vascular endothelial cells, and is essential for both physiological and pathological angiogenesis. Disruption of this gene in mice resulted in abnormal embryonic blood vessel formation. This gene is upregulated in many known tumors and its expression is correlated with tumor stage and progression. Elevated levels of this protein are found in patients with POEMS syndrome, also known as Crow-Fukase syndrome. Allelic variants of this gene have been associated with microvascular complications of diabetes 1 (MVCD1) and atherosclerosis. Alternatively spliced transcript variants encoding different isoforms have been described. There is also evidence for alternative translation initiation from upstream non-AUG (CUG) codons resulting in additional isoforms. A recent study showed that a C-terminally extended isoform is produced by use of an alternative in-frame translation termination codon via a stop codon readthrough mechanism, and that this isoform is antiangiogenic. Expression of some isoforms derived from the AUG start codon is regulated by a small upstream open reading frame, which is located within an internal ribosome entry site. |
Anti-VEGF antibody |
|||
STJ97787 | St John's Laboratory | 200 µl | EUR 236.4 |
Description: Rabbit polyclonal to VEGF. |
Polyclonal Goat anti-GST α-form |
|||
GST-ANTI-1 | Detroit R&D | 50 uL | EUR 336 |
Polyclonal Goat anti-GST μ-form |
|||
GST-ANTI-2 | Detroit R&D | 50 uL | EUR 336 |
Polyclonal Goat anti-GST p-form |
|||
GST-ANTI-3 | Detroit R&D | 50 uL | EUR 336 |
Naja mossambica Snake venom metalloproteinase-disintegrin-like mocarhagin |
|||
1-CSB-EP606027NAH | Cusabio |
|
|
Description: Recombinant Naja mossambica Snake venom metalloproteinase-disintegrin-like mocarhagin expressed in E.coli |
Anti-VEGF Antibody Clone VEGF/1063, Unconjugated-100ug |
|||
7422-MSM1-P1 | EnQuireBio | 100ug | EUR 513.6 |
Anti-VEGF-C Antibody |
|||
A00623 | BosterBio | 100ul | EUR 476.4 |
Description: Rabbit Polyclonal Antibody for VEGF-C Antibody (VEGFC) detection.tested for IHC, WB in Human, Mouse, Rat. |
Anti-VEGF/Vegfa Antibody |
|||
A00045 | BosterBio | 100ug/vial | EUR 352.8 |
Anti-VEGF/VEGF164 Antibody |
|||
A00045-1 | BosterBio | 100ug/vial | EUR 352.8 |
Anti-VEGF/Vegfa Antibody |
|||
A00045-2 | BosterBio | 100ug/vial | EUR 352.8 |
Anti-VEGF/VEGFA Antibody |
|||
PA1080 | BosterBio | 100ug/vial | EUR 400.8 |
Anti-VEGF/VEGFA Antibody |
|||
PB9071 | BosterBio | 100ug/vial | EUR 400.8 |
Anti-VEGF-C antibody |
|||
STJ96662 | St John's Laboratory | 200 µl | EUR 236.4 |
Description: Rabbit polyclonal to VEGF-C. |
Anti-VEGF-B antibody |
|||
STJ96851 | St John's Laboratory | 200 µl | EUR 236.4 |
Description: Rabbit polyclonal to VEGF-B. |
anti-VEGF Receptor 1 |
|||
YF-PA11817 | Abfrontier | 50 ug | EUR 435.6 |
Description: Mouse polyclonal to VEGF Receptor 1 |
anti-VEGF Receptor 1 |
|||
YF-PA11818 | Abfrontier | 100 ug | EUR 483.6 |
Description: Rabbit polyclonal to VEGF Receptor 1 |
anti-VEGF Receptor 3 |
|||
YF-PA23727 | Abfrontier | 50 ul | EUR 400.8 |
Description: Mouse polyclonal to VEGF Receptor 3 |
Anti-VEGF Neutralizing Antibody |
|||
79478-1 | BPS Bioscience | 50 µg | EUR 355 |
Description: Anti-VEGF recombinant Human antibody. This antibody not been tested for cross-reactivity with other species. |
Anti-VEGF Neutralizing Antibody |
|||
79478-2 | BPS Bioscience | 100 g | EUR 460 |
Description: Anti-VEGF recombinant Human antibody. This antibody not been tested for cross-reactivity with other species. |
VEGF receptor Flt-1 (F56), Peptide Aptamer, FITC labelled |
|||
AP-334-F | Alpha Diagnostics | 1 mg | Ask for price |
Bovine Endocrine Gland Derived Vascular Endothelial Growth Factor (EG-VEGF) ELISA Kit |
|||
DLR-EG-VEGF-b-48T | DL Develop | 48T | EUR 591.6 |
Description: A sandwich quantitative ELISA assay kit for detection of Bovine Endocrine Gland Derived Vascular Endothelial Growth Factor (EG-VEGF) in samples from serum, plasma or other biological fluids. |
Bovine Endocrine Gland Derived Vascular Endothelial Growth Factor (EG-VEGF) ELISA Kit |
|||
DLR-EG-VEGF-b-96T | DL Develop | 96T | EUR 769.2 |
Description: A sandwich quantitative ELISA assay kit for detection of Bovine Endocrine Gland Derived Vascular Endothelial Growth Factor (EG-VEGF) in samples from serum, plasma or other biological fluids. |
Human Endocrine Gland Derived Vascular Endothelial Growth Factor (EG-VEGF) ELISA Kit |
|||
DLR-EG-VEGF-Hu-48T | DL Develop | 48T | EUR 403.2 |
Description: A sandwich quantitative ELISA assay kit for detection of Human Endocrine Gland Derived Vascular Endothelial Growth Factor (EG-VEGF) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids. |
Human Endocrine Gland Derived Vascular Endothelial Growth Factor (EG-VEGF) ELISA Kit |
|||
DLR-EG-VEGF-Hu-96T | DL Develop | 96T | EUR 510 |
Description: A sandwich quantitative ELISA assay kit for detection of Human Endocrine Gland Derived Vascular Endothelial Growth Factor (EG-VEGF) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids. |
Mouse Endocrine Gland Derived Vascular Endothelial Growth Factor (EG-VEGF) ELISA Kit |
|||
DLR-EG-VEGF-Mu-48T | DL Develop | 48T | EUR 522 |
Description: A sandwich quantitative ELISA assay kit for detection of Mouse Endocrine Gland Derived Vascular Endothelial Growth Factor (EG-VEGF) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids. |
Mouse Endocrine Gland Derived Vascular Endothelial Growth Factor (EG-VEGF) ELISA Kit |
|||
DLR-EG-VEGF-Mu-96T | DL Develop | 96T | EUR 673.2 |
Description: A sandwich quantitative ELISA assay kit for detection of Mouse Endocrine Gland Derived Vascular Endothelial Growth Factor (EG-VEGF) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids. |
Rat Endocrine Gland Derived Vascular Endothelial Growth Factor (EG-VEGF) ELISA Kit |
|||
DLR-EG-VEGF-Ra-48T | DL Develop | 48T | EUR 544.8 |
Description: A sandwich quantitative ELISA assay kit for detection of Rat Endocrine Gland Derived Vascular Endothelial Growth Factor (EG-VEGF) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids. |
Rat Endocrine Gland Derived Vascular Endothelial Growth Factor (EG-VEGF) ELISA Kit |
|||
DLR-EG-VEGF-Ra-96T | DL Develop | 96T | EUR 704.4 |
Description: A sandwich quantitative ELISA assay kit for detection of Rat Endocrine Gland Derived Vascular Endothelial Growth Factor (EG-VEGF) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids. |
Bovine Endocrine Gland Derived Vascular Endothelial Growth Factor (EG-VEGF) ELISA Kit |
|||
RD-EG-VEGF-b-48Tests | Reddot Biotech | 48 Tests | EUR 592.8 |
Bovine Endocrine Gland Derived Vascular Endothelial Growth Factor (EG-VEGF) ELISA Kit |
|||
RD-EG-VEGF-b-96Tests | Reddot Biotech | 96 Tests | EUR 820.8 |
Human Endocrine Gland Derived Vascular Endothelial Growth Factor (EG-VEGF) ELISA Kit |
|||
RD-EG-VEGF-Hu-48Tests | Reddot Biotech | 48 Tests | EUR 380.4 |
Human Endocrine Gland Derived Vascular Endothelial Growth Factor (EG-VEGF) ELISA Kit |
|||
RD-EG-VEGF-Hu-96Tests | Reddot Biotech | 96 Tests | EUR 517.2 |
Mouse Endocrine Gland Derived Vascular Endothelial Growth Factor (EG-VEGF) ELISA Kit |
|||
RD-EG-VEGF-Mu-48Tests | Reddot Biotech | 48 Tests | EUR 514.8 |
Mouse Endocrine Gland Derived Vascular Endothelial Growth Factor (EG-VEGF) ELISA Kit |
|||
RD-EG-VEGF-Mu-96Tests | Reddot Biotech | 96 Tests | EUR 709.2 |
Rat Endocrine Gland Derived Vascular Endothelial Growth Factor (EG-VEGF) ELISA Kit |
|||
RD-EG-VEGF-Ra-48Tests | Reddot Biotech | 48 Tests | EUR 540 |
Rat Endocrine Gland Derived Vascular Endothelial Growth Factor (EG-VEGF) ELISA Kit |
|||
RD-EG-VEGF-Ra-96Tests | Reddot Biotech | 96 Tests | EUR 746.4 |
Bovine Endocrine Gland Derived Vascular Endothelial Growth Factor (EG-VEGF) ELISA Kit |
|||
RDR-EG-VEGF-b-48Tests | Reddot Biotech | 48 Tests | EUR 619.2 |
Bovine Endocrine Gland Derived Vascular Endothelial Growth Factor (EG-VEGF) ELISA Kit |
|||
RDR-EG-VEGF-b-96Tests | Reddot Biotech | 96 Tests | EUR 859.2 |
Human Endocrine Gland Derived Vascular Endothelial Growth Factor (EG-VEGF) ELISA Kit |
|||
RDR-EG-VEGF-Hu-48Tests | Reddot Biotech | 48 Tests | EUR 396 |
Human Endocrine Gland Derived Vascular Endothelial Growth Factor (EG-VEGF) ELISA Kit |
|||
RDR-EG-VEGF-Hu-96Tests | Reddot Biotech | 96 Tests | EUR 540 |
Mouse Endocrine Gland Derived Vascular Endothelial Growth Factor (EG-VEGF) ELISA Kit |
|||
RDR-EG-VEGF-Mu-48Tests | Reddot Biotech | 48 Tests | EUR 536.4 |
Mouse Endocrine Gland Derived Vascular Endothelial Growth Factor (EG-VEGF) ELISA Kit |
|||
RDR-EG-VEGF-Mu-96Tests | Reddot Biotech | 96 Tests | EUR 741.6 |
Rat Endocrine Gland Derived Vascular Endothelial Growth Factor (EG-VEGF) ELISA Kit |
|||
RDR-EG-VEGF-Ra-48Tests | Reddot Biotech | 48 Tests | EUR 564 |
Rat Endocrine Gland Derived Vascular Endothelial Growth Factor (EG-VEGF) ELISA Kit |
|||
RDR-EG-VEGF-Ra-96Tests | Reddot Biotech | 96 Tests | EUR 781.2 |
anti-Apolipoprotein F |
|||
YF-PA10244 | Abfrontier | 50 ul | EUR 435.6 |
Description: Mouse polyclonal to Apolipoprotein F |
anti-Apolipoprotein F |
|||
YF-PA10245 | Abfrontier | 50 ug | EUR 435.6 |
Description: Mouse polyclonal to Apolipoprotein F |
anti-Apolipoprotein F |
|||
YF-PA10246 | Abfrontier | 100 ug | EUR 483.6 |
Description: Rabbit polyclonal to Apolipoprotein F |
anti-Cyclophilin F |
|||
YF-PA25484 | Abfrontier | 50 ul | EUR 400.8 |
Description: Mouse polyclonal to Cyclophilin F |
anti-Cathepsin F |
|||
YF-PA15821 | Abfrontier | 50 ul | EUR 435.6 |
Description: Mouse polyclonal to Cathepsin F |
anti-Cathepsin F |
|||
YF-PA15822 | Abfrontier | 50 ug | EUR 435.6 |
Description: Mouse polyclonal to Cathepsin F |
VEGF receptor KDR/Flk-1 (K237), Peptide Aptamer, FITC labelled |
|||
AP-336-F | Alpha Diagnostics | 1 mg | Ask for price |
VEGF |
|||
LF-PR009 | Abfrontier | 10 ug | EUR 306 |
Description: VEGF protein |
VEGF |
|||
MO15067 | Neuromics | 500 ug | EUR 1092 |
VEGF |
|||
PR15028 | Neuromics | 10 ug | EUR 553.2 |
VEGF receptor KDR and Flt-1 (v107), Peptide Aptamer, FITC labelled |
|||
AP-335-F | Alpha Diagnostics | 1 mg | Ask for price |
VEGF-stimulated Human Umbilical Vein Endothelial Cell, Peptide Aptamer, FITC labelled |
|||
AP-338-F | Alpha Diagnostics | 1 mg | Ask for price |
VEGF-stimulated human umbilical vein endothelial cells, Peptide Aptamer, FITC labelled |
|||
AP-339-F | Alpha Diagnostics | 1 mg | Ask for price |
Mouse IgG F(c)-FITC conjugate (isotype control) |
|||
20008-Fc-F | Alpha Diagnostics | 100 ug | EUR 196.8 |
Rabbit IgG F(c)-FITC conjugate, isotype control |
|||
20009-Fc-F | Alpha Diagnostics | 100 ug | EUR 196.8 |
Goat IgG F(ab')2 fragment-FITC conjugate |
|||
20011-FAB2-F | Alpha Diagnostics | 100 tests | EUR 242.4 |
Anti-VEGF-A Humanized Antibody |
|||
A2136-100 | Biovision | 100 µg | EUR 612 |
Anti-VEGF Rabbit Monoclonal Antibody |
|||
M00045-1 | BosterBio | 100ug/vial | EUR 476.4 |
Description: Rabbit Monoclonal VEGF Antibody. Validated in Flow Cytometry, IP, IF, IHC, ICC and tested in Human, Mouse. |
Anti-VEGF Receptor 3 (5B6) |
|||
YF-MA10355 | Abfrontier | 100 ug | EUR 435.6 |
Description: Mouse monoclonal to VEGF Receptor 3 |
Anti-VEGF Receptor 3 (5F11) |
|||
YF-MA13094 | Abfrontier | 100 ug | EUR 435.6 |
Description: Mouse monoclonal to VEGF Receptor 3 |
Anti-VEGF Receptor 3 (6F9) |
|||
YF-MA13095 | Abfrontier | 100 ug | EUR 435.6 |
Description: Mouse monoclonal to VEGF Receptor 3 |
Anti-VEGF Receptor 3 (5B5) |
|||
YF-MA13096 | Abfrontier | 100 ug | EUR 435.6 |
Description: Mouse monoclonal to VEGF Receptor 3 |
Anti-VEGF Receptor 3 (4D1) |
|||
YF-MA13097 | Abfrontier | 100 ug | EUR 435.6 |
Description: Mouse monoclonal to VEGF Receptor 3 |
Anti-VEGF Receptor 3 (2E3) |
|||
YF-MA13098 | Abfrontier | 100 ug | EUR 435.6 |
Description: Mouse monoclonal to VEGF Receptor 3 |
Anti-VEGF Receptor 3 (1C1) |
|||
YF-MA13099 | Abfrontier | 100 ug | EUR 435.6 |
Description: Mouse monoclonal to VEGF Receptor 3 |
Anti-VEGF Receptor 3 (6B7) |
|||
YF-MA13100 | Abfrontier | 100 ug | EUR 435.6 |
Description: Mouse monoclonal to VEGF Receptor 3 |
Anti-VEGF Receptor 2 (2A2) |
|||
YF-MA13909 | Abfrontier | 100 ug | EUR 435.6 |
Description: Mouse monoclonal to VEGF Receptor 2 |
Anti-VEGF Receptor 2 (4A2) |
|||
YF-MA13910 | Abfrontier | 100 ug | EUR 435.6 |
Description: Mouse monoclonal to VEGF Receptor 2 |
Anti-VEGF Receptor 2 (2C5) |
|||
YF-MA13911 | Abfrontier | 100 ug | EUR 435.6 |
Description: Mouse monoclonal to VEGF Receptor 2 |
Anti-VEGF Receptor 2 (4B5) |
|||
YF-MA13912 | Abfrontier | 100 ug | EUR 435.6 |
Description: Mouse monoclonal to VEGF Receptor 2 |
Anti-VEGF Receptor 2 (4F1) |
|||
YF-MA13913 | Abfrontier | 100 ug | EUR 435.6 |
Description: Mouse monoclonal to VEGF Receptor 2 |
Anti-VEGF (Bevacizumab), humanized Antibody |
|||
A1045-100 | Biovision | each | EUR 601.2 |
Mouse IgG F(ab')2-FITC conjugate (isotype control) |
|||
20008-Fab2-F | Alpha Diagnostics | 100 ug | EUR 196.8 |
Rabbit IgG F(ab')2-FITC conjugate, isotype control |
|||
20009-FAb2-F | Alpha Diagnostics | 100 ug | EUR 196.8 |
VEGF-A(VEGF/1063) Antibody |
|||
BNCA1063-250 | Biotium | 250uL | EUR 459.6 |
Description: Primary antibody against VEGF-A(VEGF/1063), APC conjugate, Concentration: 0.1mg/mL |
VEGF-A(VEGF/1063) Antibody |
|||
BNCAP1063-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against VEGF-A(VEGF/1063), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
VEGF-A(VEGF/1063) Antibody |
|||
BNCAP1063-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against VEGF-A(VEGF/1063), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
VEGF-A(VEGF/1063) Antibody |
|||
BNC611063-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against VEGF-A(VEGF/1063), CF660R conjugate, Concentration: 0.1mg/mL |
VEGF-A(VEGF/1063) Antibody |
|||
BNC611063-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against VEGF-A(VEGF/1063), CF660R conjugate, Concentration: 0.1mg/mL |
VEGF-A(VEGF/1063) Antibody |
|||
BNUM1063-50 | Biotium | 50uL | EUR 474 |
Description: Primary antibody against VEGF-A(VEGF/1063), 1mg/mL |
VEGF-A(VEGF/1063) Antibody |
|||
BNCR1063-250 | Biotium | 250uL | EUR 459.6 |
Description: Primary antibody against VEGF-A(VEGF/1063), RPE conjugate, Concentration: 0.1mg/mL |
Impression of diabetes mellitus on feminine topics present process transcatheter aortic valve implantation: Insights from the WIN-TAVI worldwide registry
Background: Feminine topics represent half of all transcatheter aortic valve implantation (TAVI) candidates, however the affiliation between necessary comorbidities resembling diabetes mellitus (DM) and medical outcomes after TAVI stays unclear on this group.
Methodology: WIN-TAVI is a real-world worldwide registry of solely feminine topics present process TAVI. The examine inhabitants was stratified into these with (DM) and people with out DM (NDM). Valve Educational Analysis Consortium (VARC)-2 efficacy (composite of all-cause dying, stroke, myocardial infarction, hospitalization for valve-related signs or worsening congestive coronary heart failure, or valve-related dysfunction) was the first endpoint for this evaluation.
Outcomes: Of the 1012 topics included on this examine, 264 (26.1%) had DM at baseline. DM sufferers had been youthful however had a better burden of comorbidities. There have been no variations in VARC-2 efficacy occasions between DM and NDM sufferers at 30 days or 1 yr. Conversely, sufferers with DM had a decrease threat of VARC-2 life threatening bleeding at 30 days and 1 yr after TAVI in comparison with NDM sufferers, which remained important even after multivariable adjustment (HR, 0.34, 95% CI, 0.12-0.99; p = .047). Within the subgroup evaluation, insulin-dependent DM was not related to an elevated threat of hostile outcomes.
Conclusions: Amongst feminine sufferers present process TAVI, greater than one-fourth of the themes offered with DM. At 1-year follow-up, DM was related to decrease bleeding issues and no improve within the threat of different hostile occasions, together with mortality, after TAVI.
The Position of Diabetes Mellitus as an Impact Modifier of the Affiliation Between Smoking Cessation and Its Medical Prognoses: An Observational Cohort Research
The smoker’s paradox refers to an elevated threat of hostile medical outcomes after smoking cessation in sufferers with coronary artery illness. The mechanisms concerned are controversial. The current examine evaluated the impact of delay in smoking cessation on medical outcomes amongst sufferers after percutaneous coronary intervention (PCI) stratified by diabetes mellitus (DM). Sufferers included on this examine got here from a longtime Fu Wai hospital PCI cohort. Smoking conduct was recorded; medical finish factors included all-cause mortality and repeat revascularization.
The analyses had been based mostly on 8489 people who smoke who underwent PCI. Sufferers with and with out DM had been examined individually. Multivariable mannequin evaluation urged that smoking cessation was related to important decrease all-cause mortality each for non-DM and DM sufferers. The smoking paradox was noticed for revascularization. Nonetheless, the elevated threat of repeat revascularization correlated with quitting time amongst non-DM sufferers solely, particularly in the event that they stopped smoking late (>90 days) after their index process (adjusted hazard ratio, 3.40; 95% CI: 2.45-4.72). In conclusion, smoking cessation is related to a decrease mortality fee for PCI sufferers. Nonetheless, the relative profit on repeated revascularization was solely noticed amongst non-DM sufferers in the event that they stop smoking early.
GRO/KC (CXCL1), Rat Recombinant |
|||
P1288-25 | Biovision | each | EUR 444 |
GRO/KC (CXCL1), Rat Recombinant |
|||
P1288-5 | Biovision | each | EUR 210 |
GRO1/KC Mouse, GRO/KC (CXCL1) Mouse Recombinant Protein, His Tag |
|||
PROTP12850 | BosterBio | Regular: 20ug | EUR 380.4 |
Description: GRO1/KC Mouse Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing 97 amino acids (25-96 a.a.) and having a molecular mass of 10.5kDa.;GRO1 is fused to a 25 amino acid His-tag at N-terminus & purified by proprietary chromatographic techniques. |
GRO-alpha, KC, CXCL1 (rMuKC), murine (mouse) |
|||
RC332-12 | Bio Basic | 5ug | EUR 125.26 |
Recombinant Rat GRO/KC (CXCL1) Protein |
|||
PROTP14095-1 | BosterBio | 25ug | EUR 380.4 |
Description: All three isoforms of GRO are CXC chemokines that can signal through the CXCR1 or CXCR2 receptors. The GRO proteins chemoattract and activate neutrophils and basophils. Recombinant rat GRO/KC is a 7.8 kDa protein consisting of 72 amino acids including the 'ELR' motif common to the CXC chemokine family that bind to CXCR1 or CXCR2. |
Rat CXCL1/CINC-1/KC ELISA Kit |
|||
RK00196 | Abclonal | 96 Tests | EUR 625.2 |
Mouse CXC-chemokine ligand 1(CXCL1/KC)ELISA Kit |
|||
YLA0122MO-48T | Shanghai YL Biotech | 48T | EUR 465 |
Mouse CXC-chemokine ligand 1(CXCL1/KC)ELISA Kit |
|||
YLA0122MO-96T | Shanghai YL Biotech | 96T | EUR 600 |
KC protein (Mouse) |
|||
30R-AK001 | Fitzgerald | 20 ug | EUR 327.6 |
Description: Purified recombinant Mouse KC protein |
Anti-CXCL1 antibody |
|||
STJ28366 | St John's Laboratory | 100 µl | EUR 332.4 |
Description: This antimicrobial gene encodes a member of the CXC subfamily of chemokines. The encoded protein is a secreted growth factor that signals through the G-protein coupled receptor, CXC receptor 2. This protein plays a role in inflammation and as a chemoattractant for neutrophils. Aberrant expression of this protein is associated with the growth and progression of certain tumors. A naturally occurring processed form of this protein has increased chemotactic activity. Alternate splicing results in coding and non-coding variants of this gene. A pseudogene of this gene is found on chromosome 4. |
Anti-CXCL1 antibody |
|||
STJ72026 | St John's Laboratory | 100 µg | EUR 312 |
Rabbit Polyclonal antibody Anti-CRBN |
|||
Anti-CRBN | ImmunoStep | 50 µg | EUR 418.8 |
KC antibody |
|||
70R-KR006 | Fitzgerald | 50 ug | EUR 327.6 |
Description: Affinity purified Rabbit polyclonal KC antibody |
KC antibody |
|||
70R-12297 | Fitzgerald | 100 ug | EUR 632.4 |
Description: Rabbit polyclonal KC antibody |
KC antibody |
|||
70R-12298 | Fitzgerald | 100 ug | EUR 590.4 |
Description: Rabbit polyclonal KC antibody |
KC antibody |
|||
20R-1786 | Fitzgerald | 100 ug | EUR 781.2 |
Description: Rabbit polyclonal KC antibody |
KC Antibody |
|||
5211-100 | Biovision | each | EUR 451.2 |
KC Antibody |
|||
5212-100 | Biovision | each | EUR 470.4 |
KC Antibody |
|||
5212-30T | Biovision | each | EUR 175.2 |
Rabbit Anti Mouse Cxcl1 Polyclonal Antibody |
|||
CPBT-65100RM | Creative Diagnostics | 0.1 mg | EUR 1057.2 |
anti-7-ketocholesterol (7-KC) (35A) |
|||
LF-MA90006 | Abfrontier | 20 ug | EUR 1230 |
Description: Mouse monoclonal to 7-ketocholesterol (7-KC) |
anti-7-ketocholesterol (7-KC) (35A) |
|||
LF-MA90007 | Abfrontier | 100 ug | EUR 3270 |
Description: Mouse monoclonal to 7-ketocholesterol (7-KC) |
KC Recombinant Protein |
|||
40-339-0005mg | ProSci | 0.005 mg | EUR 311.1 |
Description: All three isoforms of GRO are CXC chemokines that can signal through the CXCR1 or CXCR2 receptors. The GRO proteins chemoattract and activate neutrophils and basophils. Recombinant murine KC is a 7.8 kDa protein consisting of 72 amino acids including the 'ELR' motif common to the CXC chemokine family that bind to CXCR1 or CXCR2. |
KC Recombinant Protein |
|||
40-339-002mg | ProSci | 0.02 mg | EUR 437.1 |
Description: All three isoforms of GRO are CXC chemokines that can signal through the CXCR1 or CXCR2 receptors. The GRO proteins chemoattract and activate neutrophils and basophils. Recombinant murine KC is a 7.8 kDa protein consisting of 72 amino acids including the 'ELR' motif common to the CXC chemokine family that bind to CXCR1 or CXCR2. |
KC Blocking Peptide |
|||
33R-11041 | Fitzgerald | 50 ug | EUR 229.2 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of KC antibody, catalog no. 70R-12298 |
Polyclonal KC Antibody |
|||
APR16969G | Leading Biology | 0.1mg | EUR 580.8 |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human KC . This antibody is tested and proven to work in the following applications: |
KC 12291 hydrochloride |
|||
B7332-10 | ApexBio | 10 mg | EUR 447.6 |
KC 12291 hydrochloride |
|||
B7332-50 | ApexBio | 50 mg | EUR 1635.6 |
KC Blocking Peptide |
|||
5212BP-50 | Biovision | each | EUR 183.6 |
Mouse CXCL1 shRNA Plasmid |
|||
20-abx970673 | Abbexa |
|
|
Mouse CXCL1 ELISA Kit |
|||
55R-1741 | Fitzgerald | 1 kit | EUR 748.8 |
Description: ELISA kit for detection of CXCL1 in the research laboratory |
GRO-alpha/CXCL1, Mouse |
|||
HY-P7188 | MedChemExpress | 50ug | EUR 639.6 |
Anti-GRO alpha/Cxcl1 Antibody |
|||
A00533 | BosterBio | 100ug/vial | EUR 352.8 |
Anti-GRO alpha/CXCL1 Antibody |
|||
PA1760 | BosterBio | 100ug/vial | EUR 352.8 |
KiloGreen 2X qPCR MasterMix-iCycler |
|||
MasterMix-KC | ABM | 4 x 1.25 ml - 500 reactions (20 ul) | EUR 168 |
Mouse keinocyte chemoattractant (KC) ELISA kit |
|||
E03K0088-192T | BlueGene | 192 tests | EUR 1524 |
Description: A sandwich ELISA for quantitative measurement of Mouse keinocyte chemoattractant (KC) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Mouse keinocyte chemoattractant (KC) ELISA kit |
|||
E03K0088-48 | BlueGene | 1 plate of 48 wells | EUR 624 |
Description: A sandwich ELISA for quantitative measurement of Mouse keinocyte chemoattractant (KC) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Mouse keinocyte chemoattractant (KC) ELISA kit |
|||
E03K0088-96 | BlueGene | 1 plate of 96 wells | EUR 822 |
Description: A sandwich ELISA for quantitative measurement of Mouse keinocyte chemoattractant (KC) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Cxcl1 Antibody |
|||
1-CSB-PA09217A0Rb | Cusabio |
|
|
Description: A polyclonal antibody against Cxcl1. Recognizes Cxcl1 from Mouse. This antibody is Unconjugated. Tested in the following application: ELISA |
CXCL1 Antibody |
|||
1-CSB-PA06097A0Rb | Cusabio |
|
|
Description: A polyclonal antibody against CXCL1. Recognizes CXCL1 from Human. This antibody is Unconjugated. Tested in the following application: ELISA |
CXCL1 Antibody |
|||
1-CSB-PA009036 | Cusabio |
|
|
Description: A polyclonal antibody against CXCL1. Recognizes CXCL1 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: IHC, ELISA;IHC:1/100-1/300.ELISA:1/10000 |
CXCL1 Antibody |
|||
1-CSB-PA006239GA01HU | Cusabio |
|
|
Description: A polyclonal antibody against CXCL1. Recognizes CXCL1 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC |
CXCL1 Antibody |
|||
43679-100ul | SAB | 100ul | EUR 302.4 |
CXCL1 antibody |
|||
70R-10502 | Fitzgerald | 50 ug | EUR 560.4 |
Description: Affinity purified rabbit polyclonal CXCL1 antibody |
CXCL1 antibody |
|||
70R-16681 | Fitzgerald | 50 ul | EUR 522 |
Description: Rabbit polyclonal CXCL1 antibody |
CXCL1 antibody |
|||
70R-14297 | Fitzgerald | 100 ug | EUR 392.4 |
Description: Affinity purified Rabbit polyclonal CXCL1 antibody |
CXCL1 antibody |
|||
70R-15473 | Fitzgerald | 100 ug | EUR 392.4 |
Description: Rabbit polyclonal CXCL1 antibody |
CXCL1 Peptide |
|||
42-129P | ProSci | 0.1 mg | EUR 405.6 |
Description: (CT) CXCL1 Peptide |
CXCL1 protein |
|||
30R-3156 | Fitzgerald | 50 ug | EUR 308.4 |
Description: Purified recombinant CXCL1 protein |
CXCL1 Antibody |
|||
33054-100ul | SAB | 100ul | EUR 302.4 |
CXCL1 siRNA |
|||
20-abx901350 | Abbexa |
|
|
CXCL1 siRNA |
|||
20-abx913248 | Abbexa |
|
|
CXCL1 siRNA |
|||
20-abx913249 | Abbexa |
|
|
CXCL1/GRO |
|||
E21-597 | EnoGene | 10ug | EUR 411.6 |
CXCL1/GRO |
|||
EF012822 | Lifescience Market | 96 Tests | EUR 826.8 |
pEGFP- CXCL1 |
|||
PVT10178 | Lifescience Market | 2 ug | EUR 361.2 |
Polyclonal Goat anti-GST α-form |
|||
GST-ANTI-1 | Detroit R&D | 50 uL | EUR 336 |
Polyclonal Goat anti-GST μ-form |
|||
GST-ANTI-2 | Detroit R&D | 50 uL | EUR 336 |
Polyclonal Goat anti-GST p-form |
|||
GST-ANTI-3 | Detroit R&D | 50 uL | EUR 336 |
KC Kimtech precision wipes |
|||
CLE7552 | Scientific Laboratory Supplies | PK30 | EUR 209.76 |
KC Delicate Task Wipes |
|||
CLE7558 | Scientific Laboratory Supplies | PK15 | EUR 126.54 |
GRO/KC, murine recombinant |
|||
4210-100 | Biovision | each | EUR 927.6 |
GRO/KC, murine recombinant |
|||
4210-1000 | Biovision | each | EUR 4627.2 |
GRO/KC, murine recombinant |
|||
4210-20 | Biovision | each | EUR 307.2 |
Mouse CXCL1 PicoKine ELISA Kit |
|||
EK0723 | BosterBio | 96 wells | EUR 547.2 |
Description: For quantitative detection of mouse CXCL1 in cell culture supernates and serum. |
ELISA kit for Mouse CXCL1 |
|||
EK5299 | SAB | 96 tests | EUR 663.6 |
Description: Enzyme-linked immunosorbent assay kit for quantification of Mouse CXCL1 in samples from serum, plasma, tissue homogenates and other biological fluids. |
Mouse CXCL1 Detection Assay Kit |
|||
6725 | Chondrex | 1 kit | EUR 580.26 |
Description: Mouse CXCL1 Detection Assay Kit |
CXCL1 protein (Mouse) (His tag) |
|||
80R-3368 | Fitzgerald | 50 ug | EUR 308.4 |
Description: Purified recombinant CXCL1 protein (Mouse) (His tag) |
CXCL1 protein (Mouse) (His tag) |
|||
80R-3439 | Fitzgerald | 50 ug | EUR 308.4 |
Description: Purified recombinant CXCL1 protein (Mouse) (His tag) |
CXCL1 ELISA Kit (Mouse) (OKBB00312) |
|||
OKBB00312 | Aviva Systems Biology | 96 Tests | EUR 652.8 |
Description: Description of target: Chemokine (C-X-C motif) ligand 1 (CXCL1) is a small cytokine belonging to the CXC chemokine family that was previously called GRO1 oncogene, GROα, KC, Neutrophil-activating protein 3 (NAP-3) and melanoma growth stimulating activity, alpha (MSGA-α). In humans, this protein is encoded by the CXCL1 gene. The gene for CXCL1 is located on human chromosome 4 amongst genes for other CXC chemokines. The mature form of CXCL1 is maximally 73 amino acids long. CXCL1 is secreted by human melanoma cells, has mitogenic properties and is implicated in melanoma pathogenesis. CXCL1 is expressed by macrophages, neutrophils and epithelial cells, and has neutrophil chemoattractant activity. This chemokine elicits its effects by signaling through the chemokine receptor CXCR2.CXCL1 decreased the severity of multiple sclerosis and may offer a neuro-protective function. The standard product used in this kit is recombinant mouse CXCL1, consisting of 77 amino acids with the molecular mass of 8KDa.;Species reactivity: Mouse;Application: ELISA;Assay info: ;Sensitivity: < 1 pg/ml |
CXCL1 ELISA Kit (Mouse) (OKAN04583) |
|||
OKAN04583 | Aviva Systems Biology | 96 Wells | EUR 950.4 |
Description: Description of target: This gene encodes a protein that is a member of the CXC subfamily of chemokines. Chemokines, which recruit and activate leukocytes, are classified by function (inflammatory or homeostatic) or by structure. This secretory protein is proposed to bind the G-protein coupled receptor chemokine (C-X-C motif) receptor 2 to recruit neutrophils. In mouse, deficiency of this gene is associated with colitis and with defects in immune cell recruitment to the lung.;Species reactivity: Mouse;Application: ELISA;Assay info: Assay Methodology: Quantitative Sandwich ELISA;Sensitivity: 6.0 pg/mL |
CXCL1 ELISA Kit (Mouse) (OKCD05712) |
|||
OKCD05712 | Aviva Systems Biology | 96 Wells | EUR 730.8 |
Description: Description of target: This gene encodes a protein that is a member of the CXC subfamily of chemokines. Chemokines, which recruit and activate leukocytes, are classified by function (inflammatory or homeostatic) or by structure. This secretory protein is proposed to bind the G-protein coupled receptor chemokine (C-X-C motif) receptor 2 to recruit neutrophils. In mouse, deficiency of this gene is associated with colitis and with defects in immune cell recruitment to the lung.;Species reactivity: Mouse;Application: ELISA;Assay info: ;Sensitivity: < 6.0pg/mL |
Mouse CXCL1/GROα ELISA kit |
|||
LF-EK50473 | Abfrontier | 1×96T | EUR 777.6 |
Cxcl1 ORF Vector (Mouse) (pORF) |
|||
ORF042286 | ABM | 1.0 ug DNA | EUR 114 |
Rabbit Anti Rat Cxcl1 Polyclonal Antibody |
|||
CPBT-65101RR | Creative Diagnostics | 0.1 mg | EUR 1057.2 |
KC ELISA Kit (Mouse) : 96 Wells (OKAG00090) |
|||
OKAG00090 | Aviva Systems Biology | 96 Wells | EUR 715.2 |
Description: Description of target: This gene encodes a protein that is a member of the CXC subfamily of chemokines. Chemokines, which recruit and activate leukocytes, are classified by function (inflammatory or homeostatic) or by structure. This secretory protein is proposed to bind the G-protein coupled receptor chemokine (C-X-C motif) receptor 2 to recruit neutrophils. In mouse, deficiency of this gene is associated with colitis and with defects in immune cell recruitment to the lung.;Species reactivity: Mouse;Application: ELISA;Assay info: Quantitative Colorimentric Sandwich ELISA;Sensitivity: 8 pg/mL |
CXCL1 Conjugated Antibody |
|||
C33054 | SAB | 100ul | EUR 476.4 |
CXCL1 cloning plasmid |
|||
CSB-CL006239HU-10ug | Cusabio | 10ug | EUR 279.6 |
Description: A cloning plasmid for the CXCL1 gene. |
CXCL1 antibody (HRP) |
|||
60R-2236 | Fitzgerald | 100 ug | EUR 392.4 |
Description: Rabbit polyclonal CXCL1 antibody (HRP) |
CXCL1 antibody (FITC) |
|||
60R-2237 | Fitzgerald | 100 ug | EUR 392.4 |
Description: Rabbit polyclonal CXCL1 antibody (FITC) |
CXCL1 antibody (biotin) |
|||
60R-2238 | Fitzgerald | 100 ug | EUR 392.4 |
Description: Rabbit polyclonal CXCL1 antibody (biotin) |
CXCL1 Recombinant Protein |
|||
91-532 | ProSci | 0.05 mg | EUR 714.3 |
Description: Chemokine (C-X-C motif) Ligand 1 Protein (CXCL1) is a growth factor for melanoma cells and a chemotaxin for neutrophils and a member of the CXC chemokine family that is a potent neutrophil attractant and activator and is also active toward basophils. CXCL1 is expressed by macrophages, neutrophils and epithelial cells; it has neutrophil chemoattractant activity. CXCL1 plays a critical nonredundant role in the development of experimental Lyme arthritis and carditis via CXCR2-mediated recruitment of neutrophils into the site of infection and may also have important pro-nociceptive effects via its direct actions on sensory neurons, and may induce long-term changes that involve protein synthesis. |
CXCL1 Recombinant Protein |
|||
91-628 | ProSci | 0.05 mg | EUR 651.3 |
Description: Cxcl1, also called Gro, Gro1, Mgsa or Scyb1, is short for growth-regulated alpha protein. The protein belongs to the intercrine alpha (chemokine CxC) family. The N-terminal processed form KC(5-72) of the protein is produced by proteolytic cleavage after secretion from bone marrow stromal cells, and shows a highly enhanced hematopoietic activity. Cxcl1 has chemotactic activity for neutrophils, and contributes to neutrophil activation during inflammation. Hematoregulatory chemokine, in vitro, suppresses hematopoietic progenitor cell proliferation. |
CXCL1 Blocking Peptide |
|||
33R-7741 | Fitzgerald | 100 ug | EUR 216 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of CXCL1 antibody, catalog no. 70R-10502 |
CXCL1 Blocking Peptide |
|||
20-abx061039 | Abbexa |
|
|
Recombinant Human CXCL1 |
|||
P0109 | FN Test | 100ug | EUR 626.83 |
Description: Recombinant Human protein for CXCL1 |
Recombinant Human CXCL1 |
|||
P0207 | FN Test | 100ug | EUR 626.83 |
Description: Recombinant Human protein for CXCL1 |
pCMV-SPORT6-CXCL1 |
|||
PVT13291 | Lifescience Market | 2 ug | EUR 469.2 |
Cxcl1 Polyclonal Antibody |
|||
A51950-020 | EpiGentek | 20 ul | EUR 117.7 |
Cxcl1 Polyclonal Antibody |
|||
A51950-050 | EpiGentek | 50 ul | EUR 302.5 |